These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11409037)
1. Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis. Chung CM; Connors LH; Benson MD; Walsh MT Amyloid; 2001 Jun; 8(2):75-83. PubMed ID: 11409037 [TBL] [Abstract][Full Text] [Related]
2. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Lashuel HA; Lai Z; Kelly JW Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152 [TBL] [Abstract][Full Text] [Related]
4. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication. Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294 [TBL] [Abstract][Full Text] [Related]
5. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Lai Z; Colón W; Kelly JW Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594 [TBL] [Abstract][Full Text] [Related]
6. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944 [TBL] [Abstract][Full Text] [Related]
7. Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin. Bateman DA; Tycko R; Wickner RB Biophys J; 2011 Nov; 101(10):2485-92. PubMed ID: 22098747 [TBL] [Abstract][Full Text] [Related]
8. The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. Lashuel HA; Wurth C; Woo L; Kelly JW Biochemistry; 1999 Oct; 38(41):13560-73. PubMed ID: 10521263 [TBL] [Abstract][Full Text] [Related]
9. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349 [TBL] [Abstract][Full Text] [Related]
10. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism. Si JB; Kim B; Kim JH Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922648 [TBL] [Abstract][Full Text] [Related]
12. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831 [TBL] [Abstract][Full Text] [Related]
13. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539 [TBL] [Abstract][Full Text] [Related]
14. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of the stabilities of synthetic Raimondi S; Mangione PP; Verona G; Canetti D; Nocerino P; Marchese L; Piccarducci R; Mondani V; Faravelli G; Taylor GW; Gillmore JD; Corazza A; Pepys MB; Giorgetti S; Bellotti V J Biol Chem; 2020 Aug; 295(33):11379-11387. PubMed ID: 32571879 [TBL] [Abstract][Full Text] [Related]
16. Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils. Criddle RS; Hansen LD; Woodfield BF; Tolley HD PLoS One; 2024; 19(6):e0304891. PubMed ID: 38843135 [TBL] [Abstract][Full Text] [Related]